focus -WSS

focus

author：leisure time 2025-08-23 08:54:46 - browse：2153

Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

focus

WSS

Beach reads and more: STAT's 2023 summer book list

Woodcock on FDA’s accelerated approval and her next chapter

Novo Nordisk to expand supply of Wegovy for U.S. patients

Leqembi, other new Alzheimer’s drugs require better biomarkers

FDA drug safety: Singulair case shows systemic surveillance flaws

Elizabeth Holmes on track for early release from her 11

Wikipedia

focus

knowledge

State Dept. review finds Biden bears some blame for Afghanistan failures

Why 40% Americans with Parkinson’s don’t see a neurologist

George Santos makes 1st court appearance after pleading not guilty to 13 counts

How the political right came to back psychedelics to treat trauma

Medical leaders decry Supreme Court decision on affirmative action

Congressmen charge Covid hearing ‘could have been an email’

Walensky prepares to leave CDC — and Congress — behind

Beach reads and more: STAT's 2023 summer book list

What does generative AI mean for health care? We asked experts

Congressmen charge Covid hearing ‘could have been an email’

focus

Beach reads and more: STAT's 2023 summer book list

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Petition to FDA: Get the lead out of consumer hair dyes

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

The real point of Kenneth Smith’s execution by nitrogen gas

Biden administration opens offers in Medicare drug price negotiations

explore

focus

focus

hotspot